Joshua Prince - Chief Operating Officer at Vistagen Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Issuer Symbol
VTGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joshua Prince since 11 Jan 2025

Holdings reported by Joshua Prince for Vistagen Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15,249 $8,579 $0.5626 31 Dec 2025 Direct
Stock Option (Right to Buy) 100,000 23 Jun 2025 Direct Common Stock

Transactions reported by Joshua Prince for Vistagen Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.